Background: Many patients with coronary artery disease (CAD) are routinely referred for surveillance stress testing despite recommendations against it. Objective: To determine whether low levels of resting high-sensitivity cardiac troponin I (hs-cTnI) can identify persons without inducible myocardial ischemia. Design: Observational study. Setting: A university-affiliated hospital network. Patients: Persons with stable CAD: 589 in the derivation group and 118 in the validation cohort. Measurements: Presence of inducible myocardial ischemia was determined by myocardial perfusion imaging with technetium-99m single-photon emission computed tomography during either treadmill or pharmacologic stress testing. Resting plasma hs-cTnI was measured within 1 week of the stress test, and the negative predictive value (NPV) for inducible ischemia was calculated. The derivation cohort was followed for 3 years for incident cardiovascular death and myocardial infarction. Results: In the derivation cohort, 10 of 101 patients with an hs-cTnI level below 2.5 pg/mL had inducible myocardial ischemia (NPV, 90% [95% CI, 83% to 95%]) and 3 of 101 had inducible ischemia involving at least 10% of the myocardium (NPV, 97% [CI, 92% to 99%]). In the validation cohort, 4 of 32 patients with an hs-cTnI level below 2.5 pg/mL had inducible ischemia (NPV, 88% [CI, 71% to 96%]) and 2 of 32 had ischemia of 10% or greater (NPV, 94% [CI, 79% to 99%]). After a median follow-up of 3 years in the derivation cohort, no adverse events occurred in patients with an hs-cTnI level below 2.5 pg/mL, compared with 33 (7%) cardiovascular deaths or incident myocardial infarctions among those with an hs-cTnI level of 2.5 pg/mL or greater. Limitation: The data may not be applicable to a population without known CAD or to persons with unstable angina, and the modest sample sizes warrant further validation in a larger cohort. Conclusion: Very low hs-cTnI levels may be useful in excluding inducible myocardial ischemia in patients with stable CAD. Primary Funding Source: National Institutes of Health.
Background: Many patients with coronary artery disease (CAD) are routinely referred for surveillance stress testing despite recommendations against it. Objective: To determine whether low levels of resting high-sensitivity cardiac troponin I (hs-cTnI) can identify persons without inducible myocardial ischemia. Design: Observational study. Setting: A university-affiliated hospital network. Patients: Persons with stable CAD: 589 in the derivation group and 118 in the validation cohort. Measurements: Presence of inducible myocardial ischemia was determined by myocardial perfusion imaging with technetium-99m single-photon emission computed tomography during either treadmill or pharmacologic stress testing. Resting plasma hs-cTnI was measured within 1 week of the stress test, and the negative predictive value (NPV) for inducible ischemia was calculated. The derivation cohort was followed for 3 years for incident cardiovascular death and myocardial infarction. Results: In the derivation cohort, 10 of 101 patients with an hs-cTnI level below 2.5 pg/mL had inducible myocardial ischemia (NPV, 90% [95% CI, 83% to 95%]) and 3 of 101 had inducible ischemia involving at least 10% of the myocardium (NPV, 97% [CI, 92% to 99%]). In the validation cohort, 4 of 32 patients with an hs-cTnI level below 2.5 pg/mL had inducible ischemia (NPV, 88% [CI, 71% to 96%]) and 2 of 32 had ischemia of 10% or greater (NPV, 94% [CI, 79% to 99%]). After a median follow-up of 3 years in the derivation cohort, no adverse events occurred in patients with an hs-cTnI level below 2.5 pg/mL, compared with 33 (7%) cardiovascular deaths or incident myocardial infarctions among those with an hs-cTnI level of 2.5 pg/mL or greater. Limitation: The data may not be applicable to a population without known CAD or to persons with unstable angina, and the modest sample sizes warrant further validation in a larger cohort. Conclusion: Very low hs-cTnI levels may be useful in excluding inducible myocardial ischemia in patients with stable CAD. Primary Funding Source: National Institutes of Health.
Authors: G Neumayr; H Gaenzer; R Pfister; W Sturm; S P Schwarzacher; G Eibl; G Mitterbauer; H Hoertnagl Journal: Am J Cardiol Date: 2001-02-01 Impact factor: 2.778
Authors: Yunus Tanglay; Raphael Twerenbold; Gino Lee; Max Wagener; Ursina Honegger; Christian Puelacher; Tobias Reichlin; Seoung Mann; Seoung Man Sou; Sophie Druey; Thomas Hochgruber; Stephan Zürcher; Milos Radosavac; Philipp Kreutzinger; Gilles Pretre; Fabio Stallone; Petra Hillinger; Cedric Jaeger; Maria Rubini Gimenez; Michael Freese; Damian Wild; Katharina Rentsch; Stefan Osswald; Michael J Zellweger; Christian Mueller Journal: Am J Med Date: 2015-01-30 Impact factor: 4.965
Authors: Eduard M Laufer; Alma M A Mingels; Mark H M Winkens; Ivo A P G Joosen; Mark W M Schellings; Tim Leiner; Joachim E Wildberger; Jagat Narula; Marja P Van Dieijen-Visser; Leonard Hofstra Journal: Arterioscler Thromb Vasc Biol Date: 2010-03-18 Impact factor: 8.311
Authors: Gino Lee; Raphael Twerenbold; Yunus Tanglay; Tobias Reichlin; Ursina Honegger; Max Wagener; Cedric Jaeger; Maria Rubini Gimenez; Thomas Hochgruber; Christian Puelacher; Milos Radosavac; Philipp Kreutzinger; Fabio Stallone; Petra Hillinger; Lian Krivoshei; Thomas Herrmann; Romy Mayr; Michael Freese; Damian Wild; Katharina M Rentsch; John Todd; Stefan Osswald; Michael J Zellweger; Christian Mueller Journal: Am Heart J Date: 2015-12-02 Impact factor: 4.749
Authors: Muhammad Hammadah; Ibhar Al Mheid; Kobina Wilmot; Ronnie Ramadan; Ayman Alkhoder; Malik Obideen; Naser Abdelhadi; Shuyang Fang; Ijeoma Ibeanu; Pratik Pimple; Heval Mohamed Kelli; Amit J Shah; Brad Pearce; Yan Sun; Ernest V Garcia; Michael Kutner; Qi Long; Laura Ward; J Douglas Bremner; Fabio Esteves; Paolo Raggi; David Sheps; Viola Vaccarino; Arshed A Quyyumi Journal: JACC Cardiovasc Imaging Date: 2017-03-15
Authors: Torbjørn Omland; Marc A Pfeffer; Scott D Solomon; James A de Lemos; Helge Røsjø; Jūratė Šaltytė Benth; Aldo Maggioni; Michael J Domanski; Jean L Rouleau; Marc S Sabatine; Eugene Braunwald Journal: J Am Coll Cardiol Date: 2013-02-13 Impact factor: 24.094
Authors: Laura P Kimble; Sandra B Dunbar; William S Weintraub; Deborah B McGuire; Sharon Fazio; Anindya K De; Ora Strickland Journal: Heart Dis Date: 2002 Jul-Aug
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Bruno B Lima; Muhammad Hammadah; Jeong Hwan Kim; Irina Uphoff; Amit Shah; Oleksiy Levantsevych; Zakaria Almuwaqqat; Kasra Moazzami; Samaah Sullivan; Laura Ward; Yan Sun; Michael Kutner; Yi-An Ko; David S Sheps; Agim Beshiri; Gillian Murtagh; J Douglas Bremner; Viola Vaccarino; Arshed A Quyyumi Journal: Am J Cardiol Date: 2020-09-15 Impact factor: 2.778
Authors: David M Kent; David van Klaveren; Jessica K Paulus; Ralph D'Agostino; Steve Goodman; Rodney Hayward; John P A Ioannidis; Bray Patrick-Lake; Sally Morton; Michael Pencina; Gowri Raman; Joseph S Ross; Harry P Selker; Ravi Varadhan; Andrew Vickers; John B Wong; Ewout W Steyerberg Journal: Ann Intern Med Date: 2019-11-12 Impact factor: 25.391